United States - English - NLM (National Library of Medicine)

lupin pharmaceuticals,inc. - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - trimethoprim 100 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of trimethoprim tablets, usp and other antibacterial drugs, trimethoprim tablets, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. for the treatment of initial episodes of uncomplicated urinary tract infections due to susceptible strains of the following organisms: escherichia coli , proteus mirabilis , klebsiella pneumoniae , enterobacter species, and coagulase-negative staphylococcus species, including s. saprophyticus . cultures and susceptibility tests should be performed to determine the susceptibility of the bacteria to trimethoprim. therapy may be initiated prior to obtaining the results of these tests. trimethoprim is contraindicated in individuals hypersensitive to trimethoprim and in those with documented megaloblastic anemia due to folate deficiency.

United States - English - NLM (National Library of Medicine)

avkare, inc. - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - trimethoprim 100 mg - to reduce the development of drug resistant bacteria and maintain the effectiveness of trimethoprim tablets, usp and other antibacterial drugs, trimethoprim tablets, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. for the treatment of initial episodes of uncomplicated urinary tract infections due to susceptible strains of the following organisms: escherichia coli , proteus mirabilis , klebsiella pneumoniae , enterobacter species, and coagulase-negative staphylococcus species, including s. saprophyticus . cultures and susceptibility tests should be performed to determine the susceptibility of

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - trimethoprim 100 mg - for the treatment of initial episodes of uncomplicated urinary tract infections due to susceptible strains of the following organisms: escherichiacoli, proteus mirabilis, klebsiella pneumoniae, enterobacter species and coagulase-negative staphylococcus species, including s. saprophyticus. cultures and susceptibility tests should be performed to determine the susceptibility of the bacteria to trimethoprim. therapy may be initiated prior to obtaining the results of these tests. trimethoprim tablets are contraindicated in individuals hypersensitive to trimethoprim and in those with documented megaloblastic anemia due to folate deficiency.

United States - English - NLM (National Library of Medicine)

mayne pharma - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - trimethoprim 100 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of trimethoprim tablets, usp and other antibacterial drugs, trimethoprim tablets, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. for the treatment of initial episodes of uncomplicated urinary tract infections due to susceptible strains of the following organisms: escherichia coli , proteus mirabilis , klebsiella pneumoniae , enterobacter species, and coagulase-negative staphylococcus species, including s. saprophyticus . cultures and susceptibility tests should be performed to determine the susceptibility of the bacteria to trimethoprim. therapy may be initiated prior to obtaining the

United States - English - NLM (National Library of Medicine)

novel laboratories, inc. - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - trimethoprim 100 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of trimethoprim tablets, usp and other antibacterial drugs, trimethoprim tablets, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. for the treatment of initial episodes of uncomplicated urinary tract infections due to susceptible strains of the following organisms: escherichia coli , proteus mirabilis , klebsiella pneumoniae , enterobacter species, and coagulase-negative staphylococcus species, including s. saprophyticus . cultures and susceptibility tests should be performed to determine the susceptibility of the bacteria to trimethoprim. therapy may be initiated prior to obtaining the

United States - English - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - trimethoprim 100 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of trimethoprim tablets, usp and other antibacterial drugs, trimethoprim tablets, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. for the treatment of initial episodes of uncomplicated urinary tract infections due to susceptible strains of the following organisms: escherichia coli , proteus mirabilis , klebsiella pneumoniae , enterobacter species, and coagulase-negative staphylococcus species, including s. saprophyticus . cultures and susceptibility tests should be performed to determine the susceptibility of the bacteria to trimethoprim. therapy may be initiated prior to obtaining the

United States - English - NLM (National Library of Medicine)

neogen corporation - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x), sulfadiazine (unii: 0n7609k889) (sulfadiazine - unii:0n7609k889) - trimethoprim 67 mg in 1 g - uniprim powder for horses is indicated in horses where potent systemic antibacterial action against sensitive organisms is required. uniprim powder for horses is indicated where control of bacterial infections is required during treatment of: uniprim powder for horses is well tolerated by foals. trimethoprim and sulfadiazine should not be used in horses showing marked liver parenchymal damage, blood dyscrasias, or in those with history of sulfonamide sensitivity.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ceva animal health pty ltd - trimethoprim; sulfadiazine - oral powder, pre-mix - trimethoprim pyrimidine active 130.0 mg/g; sulfadiazine sulfanyl active 650.0 mg/g - antibiotic & related - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - antibiotics - oral, parenteral | airsacculitis | amoxycillin sensitive bacteria | anaerobic bacterial infection | avian mycoplasmas | clavulanic acid sensitive | coccidiosis | coryza | crd | dermatoses | diarrhoea | endometritis | enteritis | enzootic pneumonia | escherichia coli | european brood disease | gentamicin sensitive | hypermotility | infected wounds | infections | lactating | mastitis | protozoal infections | pyometra | salmonellosis | sinusitis | systemic bacterial infection

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ausrichter pty ltd - glycine; lysine-l; methionine-dl; hyoscine methobromide; pectin; kaolin light; bismuth subcarbonate; calcium chloride; potassium chloride; magnesium sulfate; sodium acetate; trimethoprim; sulfadiazine; vitamin b2 = riboflavin; vitamin b1 hydrochloride = thiamine hydrochloride - oral tablet - glycine amino acid-glycine active 25.0 mg/100ml; lysine-l amino acid-lysine-l active 12.0 mg/100ml; methionine-dl amino acid-methionine-dl active 20.0 mg/100ml; hyoscine methobromide alkaloid active 10.0 mg/100ml; pectin carbohydrate active 1.38 g/100ml; kaolin light clay active 11.3 g/100ml; bismuth subcarbonate mineral-bismuth active 770.0 mg/100ml; calcium chloride mineral-calcium-salt active 15.0 mg/100ml; potassium chloride mineral-potassium active 20.0 mg/100ml; magnesium sulfate mineral-magnesium active 20.0 mg/100ml; sodium acetate mineral-sodium-salt active 25.0 mg/100ml; trimethoprim pyrimidine active 200.0 mg/100ml; sulfadiazine sulfanyl active 1.0 g/100ml; vitamin b2 = riboflavin vitamin-b2 active 20.0 mg/100ml; vitamin b1 hydrochloride = thiamine hydrochloride vitamin-b1 active 20.0 mg/100ml - alimentary system - calf | cattle | dog | horse | horse foal | beef | beef calf | bitch | bos indicus | bos taurus | bovine | buffalo | bull | bullo - organisms sensitive to sulphadiazine | organisms sensitive to trimethoprim

United States - English - NLM (National Library of Medicine)

aurora pharmaceutical, inc. - sulfadiazine (unii: 0n7609k889) (sulfadiazine - unii:0n7609k889), trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - sulfadiazine 333 mg in 1 ml - equisul-sdt is contraindicated in horses with a known allergy to sulfadiazine, sulfonamide class antimicrobials, or trimethoprim.